Abstract:Abstract Background Ectopic pregnancy is a major life- and fertility-threatening women’s health concern. As a result of advances in examination technology, an increasing number of ectopic pregnancies can be diagnosed early and treated with medical methods instead of surgery. The aim of this study was to summarize the clinical features and identify the predictors of success of methotrexate (MTX) treatment of ectopic pregnancy. Methods This was a retrospective study of 238 ectopic pregnancies treated with MTX in the Department of Gynecology of Shaanxi Provincial People’s Hospital from January 2017 to December 2017. Results Patients were divided into two groups: the successful treatment group ( n = 166) and the failed treatment group ( n = 72). The overall success rate of MTX therapy for ectopic pregnancy was 69.75%. The mean initial beta-human chorionic gonadotropin (β-hCG) level was significantly lower in the successful treatment group than in the failed treatment group (2538.08 IU/L versus 3533.17 IU/L, P = 0.000). The treatment success rate of the group with an initial β-hCG concentration less than 4000 IU/L was significantly higher than that of the group with an initial β-hCG concentration greater than 4000 IU/L. However, the success rate of the group with an initial β-hCG concentration greater than 4000 IU/L was still relatively high (54.55%). β-hCG levels were significantly increased on the 4th day in the failed treatment group ( P = 0.000). Compared to the initial β-hCG level, the day-4 β-hCG level increased by more than 8.21%, indicating that the treatment was effective. The diagnostic sensitivity was 88.6%, the specificity was 74.5%, and the area under the receiver operating characteristic (ROC) curve was 0.863 (95% confidence interval (CI): 0.805–0.920). Conclusions MTX therapy as a treatment option is safe and effective for asymptomatic, hemodynamically stable patients with ectopic pregnancies who are interested in conservative treatment, regardless of the serum β-hCG level or adnexal mass size. The change in the β-hCG level between the initial day and the 4th day is an effective and early predictive tool for the success of MTX therapy for ectopic pregnancy.

Study of the Conservative Treatment of 46 Ectopic Pregnancies

Clinical Analysis of 49 Cases with Ectopic Pregnancy Treating by Chinese Traditional Medicine and Western Conservative Treatment

Clinical evaluation of conservative treatment for ectopic pregnancy

Clinical Observation on Therapeutic Effect of Transvaginal Ultrasound Interventional Treatment for Ectopic Pregnancy

Interstitial Pregnancy and Transcervical Curettage

Outcome of Conservative Treatment and Subsequent Assisted Reproductive Technology for Patients with Early-Stage Endometrial Adenocarcinoma and Poor Fertility Potential

The Treatment Strategy and Prognosis of the Patients with Ectopic Pregnancy Who Desire Fertility

Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy

Successful Conservative Management with Methotrexate and Mifepristone of Cervical Pregnancy

Clinical Observation of 66 Patients with Ectopic Pregnancy Treated by Combination of Traditional Chinese with Western Medicine

A study of different conservative therapy of 11 case cervical pregnancy

Retrospective analysis of Diagnosis of Emergency Ectopic Pregnancy by Transvaginal Sonography

Analysis of risk factors and treatment outcome following methotrexate therapy in ectopic pregnancy

Analysis of Clinical Nursing Care of 26 Cases of Ectopic Pregnancy

[Single Methotrexate Chemotherapy for Low-Risk Gestational Trophoblastic Tumor].

Prophylactic Single-Dose Systemic Methotrexate Therapy for High-Risk Group in Persistent Ectopic Pregnancy After Laparoscopic Conservative Surgery of Tubal Pregnancy

The Value of Serum Β-Hcg, Progesterone and Ultrasound Examination in Monitoring Medical Therapy of Ectopic Pregnancy

[Evolution of beta-hCG titers after systemic treatment of unruptured ectopic pregnancy]

Clinical Study of the Efficacy Therapy for Persistent Ectopic Pregnancy

Clinical study on methotrexate with mifepristone in the treatment of ectopic pregnancy for 60 cases

The conservative therapy of cervical pregnancy and combined intrauterine and cervical pregnancy